CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.73%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.04B
AUM Growth
+$7.04B
(+6.8%)
Cap. Flow
+$73.9M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
55
Reduced
52
Closed
9
Top Buys
| 1 |
Citigroup
C
|
$55.6M |
| 2 |
Visa
V
|
$20.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$12.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.6M |
| 5 |
Meta Platforms (Facebook)
META
|
$11.6M |
Top Sells
| 1 |
Home Depot
HD
|
$40.1M |
| 2 |
Nike
NKE
|
$11.2M |
| 3 |
Mondelez International
MDLZ
|
$11.1M |
| 4 |
Centene
CNC
|
$10.6M |
| 5 |
Colgate-Palmolive
CL
|
$10.6M |
Sector Composition
| 1 | Financials | 27.87% |
| 2 | Healthcare | 18.82% |
| 3 | Consumer Discretionary | 16.92% |
| 4 | Communication Services | 15.48% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Mondelez International
MDLZ
$78.9B
| $31.1M | 0.44% |
764,549
-273,196
| -26% | -$11.1M |
|
|
CELG
27
DELISTED
Celgene Corp
CELG
| $26.1M | 0.37% |
179,019
-5,044
| -3% | -$736K |
|
28
Amgen
AMGN
$153B
| $20.6M | 0.29% |
110,716
-4,512
| -4% | -$841K |
|
29
Pfizer
PFE
$141B
| $19.6M | 0.28% |
549,379
-20,823
| -4% | -$743K |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $19.5M | 0.28% |
95,086
-3,704
| -4% | -$759K |
|
31
Dynavax Technologies
DVAX
$1.19B
| $17.7M | 0.25% |
823,825
+155,610
| +23% | +$3.35M |
|
|
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
| $17.4M | 0.25% |
210,627
-12,933
| -6% | -$1.07M |
|
33
Bristol-Myers Squibb
BMY
$97.1B
| $16.4M | 0.23% |
257,031
-9,981
| -4% | -$636K |
|
|
PRTK
34
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $16.2M | 0.23% |
645,100
+205,700
| +47% | +$5.16M |
|
35
Biogen
BIIB
$21B
| $15.6M | 0.22% |
49,665
-15,710
| -24% | -$4.92M |
|
36
Insmed
INSM
$30.6B
| $14M | 0.2% |
447,429
+305,958
| +216% | +$9.55M |
|
37
Merck
MRK
$213B
| $12.9M | 0.18% |
200,817
-7,252
| -3% | -$464K |
|
38
AbbVie
ABBV
$375B
| $12.7M | 0.18% |
143,271
-27,776
| -16% | -$2.47M |
|
|
39
Alphabet (Google) Class A
GOOGL
$2.77T
| $12.7M | 0.18% |
13,019
-35
| -0.3% | -$34.1K |
|
|
ALXN
40
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.5M | 0.16% |
81,944
-31,483
| -28% | -$4.42M |
|
41
Cigna
CI
$79.8B
| $11M | 0.16% |
58,777
-38,101
| -39% | -$7.12M |
|
42
Boston Scientific
BSX
$159B
| $10.7M | 0.15% |
367,194
-14,278
| -4% | -$416K |
|
43
Eli Lilly
LLY
$659B
| $10.7M | 0.15% |
125,120
-5,364
| -4% | -$459K |
|
|
SHPG
44
DELISTED
Shire pic
SHPG
| $10.6M | 0.15% |
69,219
-2,626
| -4% | -$402K |
|
45
HCA Healthcare
HCA
$95B
| $10.4M | 0.15% |
130,618
-5,534
| -4% | -$440K |
|
46
Edwards Lifesciences
EW
$48B
| $10.1M | 0.14% |
92,393
-3,869
| -4% | -$423K |
|
47
Glaukos
GKOS
$5.4B
| $9.62M | 0.14% |
291,425
+33,594
| +13% | +$1.11M |
|
|
48
Centene
CNC
$14.5B
| $9.06M | 0.13% |
93,653
-109,891
| -54% | -$10.6M |
|
49
Incyte
INCY
$17B
| $8.87M | 0.13% |
75,941
-47,783
| -39% | -$5.58M |
|
50
BioMarin Pharmaceuticals
BMRN
$11.3B
| $8.28M | 0.12% |
88,972
-14,809
| -14% | -$1.38M |
|